A precision medicine classification for treatment of acute myeloid leukemia in older patients

BACKGROUND: Older patients (≥ 60 years) with acute myeloid leukemia (AML) often have multiple, sequentially acquired, somatic mutations that drive leukemogenesis and are associated with poor outcome. Beat AML is a Leukemia and Lymphoma Society-sponsored, multicenter umbrella study that algorithmical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mims, Alice S., Kohlschmidt, Jessica, Borate, Uma, Blachly, James S., Orwick, Shelley, Eisfeld, Ann-Kathrin, Papaioannou, Dimitrios, Nicolet, Deedra, Mrόzek, Krzysztof, Stein, Eytan, Bhatnagar, Bhavana, Stone, Richard M., Kolitz, Jonathan E., Wang, Eunice S., Powell, Bayard L., Burd, Amy, Levine, Ross L., Druker, Brian J., Bloomfield, Clara D., Byrd, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220739/
https://www.ncbi.nlm.nih.gov/pubmed/34162404
http://dx.doi.org/10.1186/s13045-021-01110-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220739/
https://www.ncbi.nlm.nih.gov/pubmed/34162404
http://dx.doi.org/10.1186/s13045-021-01110-5

Ejemplares similares